USPTO serial 79421670
OPTITHYDOSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 12, 2026
- Examiner
- MMEJE, OBIEZE GINIKANWA
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with OPTITHYDOSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Paul Cosmovici
244 Fifth Avenue, 2nd Floor # suite-1279New York, NY 10001United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for predicting disease progression and determining an optimal drug dosing regimen; Recorded software for predicting disease progression and determining an optimal drug dosing regimen; downloadable Software as Medical Devices (SaMD) for predicting disease progression and determining an optimal drug dosing regimen; downloadable mobile applications for use with mobile devices for predicting disease progression and determining an optimal drug dosing regimen | ACTIVE | — |
| 035 | Collection, systematization and input of information in databases, analysis and evaluation of data in a central file, namely, collection and compilation of information into computer databases in the fields of healthcare and medical science | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design services in the field of disease progression and drug dosing; industrial analysis and research services, namely, scientific research and analysis in the field of disease progression and drug dosing; design and development of computers and software; development and testing of computing methods, algorithms and software, namely, design and development of new products for others in the field of computing and software; design and development of medical technology products for others; scientific research services in the field of disease progression and drug dosing for medical purposes; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials | ACTIVE | — |
| 044 | Health care services, medical services, provision of medical information; medical care and analysis services relating to patient treatment; performing disease diagnosis services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Universität Basel
- Other trademarks owned by Universität Basel
- Other trademarks owned by Universität Basel
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named OPTITHYDOSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 12, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 26, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 26, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 1, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 16, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 16, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 12, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 12, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 12, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 24, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 24, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 18, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 2, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 26, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 26, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 26, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 16, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 28, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 28, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 6, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 5, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 25, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 25, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 17, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |